Richard Antaya, MD
Dermatology · New Haven, CTNPI 1336130715
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $33,279 of the $37,406 with a category attached, or 89.0%. 12 manufacturers reported payments, led by Verrica Pharmaceuticals Inc. at 44.8% of the total. Reporting peaked in 2024 at $19,843 and has fallen 82.0% since, to $3,568 in 2025. Among dermatology clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 30 payments — averaging $1246.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Verrica Pharmaceuticals Inc.$17K
- Sanofi$4K
- Regeneron$4K
- Pfizer$4K
- Pierre Fabre Pharmaceuticals, Inc.$3K
- Dermavant Sciences, Inc.$3K
- plus $3K from 6 others
Across 86 payments — averaging $3560.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- LEO Pharma AS$306K
What the payments were for
- Consulting fees$33,27989%
- Travel & lodging$2,9438%
- Food & beverage$1,0843%
- Education$990%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Verrica Pharmaceuticals Inc. | 7 | $16,747 |
| Sanofi | 2 | $3,918 |
| Regeneron | 1 | $3,720 |
| Pfizer | 3 | $3,505 |
| Pierre Fabre Pharmaceuticals, Inc. | 6 | $3,282 |
| Dermavant Sciences, Inc. | 2 | $3,069 |
| LEO Pharma Inc. | 3 | $2,789 |
| Incyte Corporation | 1 | $140 |
| Arcutis Biotherapeutics, Inc. | 2 | $109 |
| Sanofi-aventis U.S. LLC | 1 | $99 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$37,406 in reported general payments places this provider in the 90th percentile of 222 dermatology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 12 | $137 |
Paid to pharmacies, not to this prescriber.
Other dermatology in New Haven
- Christopher BunickNew Haven$661K
- Keith ChoateNew Haven$362K
- David LeffellNew Haven$94K
- Mariam TotonchyNew Haven$52K
- Lisa DonofrioNew Haven$38K
- Leonard MilstoneNew Haven$31K
- William DamskyNew Haven$23K
- Michael GirardiNew Haven$20K
- Jeffrey CohenNew Haven$18K
- Mary TomaykoNew Haven$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.